# Effect of Adipokines in Hemodialysis Patients

> **NCT01301027** · NA · COMPLETED · sponsor: **University of Utah** · enrollment: 95 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01301027
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2016-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301027, "Effect of Adipokines in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01301027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
